Sonoma Pharmaceuticals, Inc. (SNOA) Free Cash Flow by Year
Sonoma Pharmaceuticals, Inc. recorded an outflow of $4.1M in free cash flow in fiscal year 2026. This represents a decrease of 2355.4% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to an outflow of $2.7M in free cash flow. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Sonoma Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SNOA Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -$2.7M | -$4.1M-2355.4% | -$168K+93.0% | -$2.4M+62.6% | -$6.4M-46.4% | -$4.4M-23.3% | -$3.6M+25.8% | -$4.8M+59.4% | -$11.8M+6.4% | -$12.6M-47.5% | -$8.6M+5.8% | -$9.1M-33.0% | -$6.8M-26.7% | -$5.4M-704.0% | $893K+120.4% | -$4.4M |
TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
SNOA Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Sonoma Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Sonoma Pharmaceuticals, Inc.'s free cash flow in fiscal year 2026?
Sonoma Pharmaceuticals, Inc. recorded an outflow of $4.1M in free cash flow in fiscal year 2026.
How fast is Sonoma Pharmaceuticals, Inc.'s free cash flow growing?
Sonoma Pharmaceuticals, Inc. (SNOA) free cash flow fell by 2355.4% year over year, from -$168K to -$4.1M in fiscal year 2026.
What is Sonoma Pharmaceuticals, Inc.'s free cash flow over the last twelve months?
Sonoma Pharmaceuticals, Inc. (SNOA) reported an outflow of $2.7M in free cash flow over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
How has Sonoma Pharmaceuticals, Inc.'s free cash flow changed over the years?
Across the 15 fiscal years this page covers, Sonoma Pharmaceuticals, Inc. (SNOA) free cash flow went from -$4.4M in fiscal year 2012 to -$4.1M in fiscal year 2026.
What was Sonoma Pharmaceuticals, Inc.'s free cash flow in the most recent quarter?
Sonoma Pharmaceuticals, Inc. (SNOA) reported -$651K in free cash flow in Q1 2027. This represents an increase of 69.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Sonoma Pharmaceuticals, Inc. (SNOA) reported on that line in every period on record.